Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Coronary Events Study (ACES)
NCT00000617Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of azithromycin in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Sep 1998; status: completed.
02
Drugs
azithromycin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00000617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000617.